Drug information for APTIVUS

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 250MG Prescription  (Reference Drug) TIPRANAVIR tipranavir BOEHRINGER INGELHEIM 21814
2012-02-27 Letter
2012-02-22 Label
2011-04-07 Letter
2011-04-06 Label
2010-09-07 Letter
2010-08-16 Label
2010-05-12 Summary Review
2010-05-12 Review
2010-05-07 Label
2010-05-03 Letter
2009-06-24 Label
2009-06-24 Letter
2008-06-26 Letter
2008-06-26 Label
2007-10-10 Label
2007-10-10 Letter
2007-05-29 Letter
2006-08-18 Letter
2006-08-18 Letter
2006-08-14 Label
2006-08-14 Label
2005-09-02 Review
2005-06-24 Letter
2005-06-23 Label
SOLUTION; ORAL 100MG/ML Prescription  (Reference Drug) TIPRANAVIR tipranavir BOEHRINGER INGELHEIM 21822
2010-04-21 Review
2010-04-21 Summary Review
2008-06-26 Label
2008-06-26 Letter
SOLUTION; ORAL 100MG/ML Prescription  (Reference Drug) TIPRANAVIR tipranavir BOEHRINGER INGELHEIM 22292
2012-02-27 Letter
2012-02-22 Label
2011-04-07 Letter
2011-04-06 Label
2010-09-07 Letter
2010-08-16 Label
2010-05-12 Review
2010-05-12 Summary Review
2010-05-07 Label
2010-05-03 Letter
2009-06-24 Letter
2009-06-24 Label
2008-06-26 Label
2008-06-26 Letter

Drug Adverse Effects information for APTIVUS

Role code Indications Reaction # Reports
C HIV INFECTION LUNG NEOPLASM MALIGNANT 9
C PRODUCT USED FOR UNKNOWN INDICATION LUNG NEOPLASM MALIGNANT 1
Ads by Google